IndraLab

Statements


MT2-2 peptide inhibits KCNQ1. 1 / 1
| 1

reach
"With MT2 as a new template, we further designed a more potent MT2-2 peptide, which selectively inhibited the KCNQ1 and KCNE1 channel with an IC50 of 1.51 +/-0.62 muM."